The Cardiology Transgenic and Knockout Core Facility was created in 1998 to serve the needs of investigators within the Cardiology Division and to foster collaborations outside the Division. Although other transgenic core facilities exist at the University of Pennsylvania, these facilities are in heavy demand and waiting time commonly averages several months before injection of constructs. Therefore, the Cardiology division committed significant divisional resources towards the establishment of a fully functional core within Cardiology that could promptly and efficiently serve the needs of divisional investigators. The Molecular Cardiology Transgenic and Knockout Core generates transgenic mice through DNA injection of oocytes and knockout mice through ES cell injection into btastocysts. The continued heavy use of other University transgenic facilities continues to make this independent core extremely valuable to the timely progression of our research efforts. Since many of the projects proposed in this program rely upon the creation of multiple transgenic and knockout mice, prompt service from a successful Transgenic Core will be ssential to the success of this program.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL075215-04
Application #
7433795
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2007-06-01
Budget End
2008-05-31
Support Year
4
Fiscal Year
2007
Total Cost
$305,205
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Zhou, Zinan; Tang, Alan T; Wong, Weng-Yew et al. (2016) Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling. Nature 532:122-6
Liu, Chunhong; Morishima, Masae; Jiang, Xiaoling et al. (2014) Engineered chromosome-based genetic mapping establishes a 3.7 Mb critical genomic region for Down syndrome-associated heart defects in mice. Hum Genet 133:743-53
Degenhardt, Karl R; Milewski, Rita C; Padmanabhan, Arun et al. (2010) Distinct enhancers at the Pax3 locus can function redundantly to regulate neural tube and neural crest expressions. Dev Biol 339:519-27
Rentschler, Stacey; Jain, Rajan; Epstein, Jonathan A (2010) Tissue-tissue interactions during morphogenesis of the outflow tract. Pediatr Cardiol 31:408-13
Stoller, Jason Z; Huang, Li; Tan, Cheryl C et al. (2010) Ash2l interacts with Tbx1 and is required during early embryogenesis. Exp Biol Med (Maywood) 235:569-76
Tian, Ying; Yuan, Lijun; Goss, Ashley M et al. (2010) Characterization and in vivo pharmacological rescue of a Wnt2-Gata6 pathway required for cardiac inflow tract development. Dev Cell 18:275-87
Jain, Rajan; Rentschler, Stacey; Epstein, Jonathan A (2010) Notch and cardiac outflow tract development. Ann N Y Acad Sci 1188:184-90
Degenhardt, Karl; Wright, Alexander C; Horng, Debra et al. (2010) Rapid 3D phenotyping of cardiovascular development in mouse embryos by micro-CT with iodine staining. Circ Cardiovasc Imaging 3:314-22
Hickey, Michele M; Richardson, Theresa; Wang, Tao et al. (2010) The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice. J Clin Invest 120:827-39
Parmacek, Michael S; Epstein, Jonathan A (2009) Cardiomyocyte renewal. N Engl J Med 361:86-8

Showing the most recent 10 out of 34 publications